Financials
- Market Capitalization 25.21 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
15.41
Fiyat/satışlar oranı
3.86
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 488 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 60.85 USD | -1.73% | -0.44% | +4.11% | +63.31% | 27.17 B USD | ||
| 504 | INSM Insmed Incorporated - Common Stock | 118.54 USD | -2.35% | -5.58% | +17.22% | -26.85% | 25.89 B USD | ||
| 516 | ROIV Roivant Sciences Ltd. - Common Shares | 34.71 USD | -7.64% | -3.85% | +3.33% | +89.57% | 25.07 B USD | ||
| 527 | BNTX BioNTech SE - American Depositary Shares | 102.08 USD | -8.37% | -10.57% | +10.81% | +2.09% | 24.50 B USD |